metastases

You have access
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors
SANDRINE OZIEL-TAIEB, CHRISTOPHE ZEMMOUR, JEAN-LUC RAOUL, LAURENT MINEUR, FLORA POIZAT, NATHALIE CHARRIER, GILLES PIANA, GERARD CAVAGLIONE and PATRICIA NICCOLI

Anticancer Research April 2021, 41 (4) 2071-2078; DOI: https://doi.org/10.21873/anticanres.14977
You have access
Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma
JEROME H. CHECK, DIANE CHECK, TRINA PORETTA and CARRIE WILSON

Anticancer Research April 2021, 41 (4) 2111-2115; DOI: https://doi.org/10.21873/anticanres.14982
You have access
Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer
LORENZO BORGOGNONI, LEONARDO PESCITELLI, GIANNI GERLINI, PAOLA BRANDANI, RICCARDO GELLI, VANNI GIANNOTTI, FRANCESCO BELLUCCI and SERENA SESTINI

Anticancer Research November 2020, 40 (11) 6485-6492; DOI: https://doi.org/10.21873/anticanres.14670
You have access
MRI Lymph Node Evaluation for Prediction of Metastases in Rectal Cancer
KARIN ALMLÖV, MISCHA WOISETSCHLÄGER, PER LOFTÅS, OLOF HALLBÖÖK, NILS O. ELANDER and PER SANDSTRÖM

Anticancer Research May 2020, 40 (5) 2757-2763; DOI: https://doi.org/10.21873/anticanres.14247
You have access
MRI in the Follow-up of Testicular Cancer: Less is More
ERIK RUD, CARL WILHELM LANGBERG, EDUARD BACO, PETER LAURITZEN and GUNNAR SANDBÆK

Anticancer Research June 2019, 39 (6) 2963-2968; DOI: https://doi.org/10.21873/anticanres.13427
You have access
Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy
JAZAN OMARI, CONSTANZE HEINZE, ROBERT DAMM, PETER HASS, ANDREAS JANITZKY, JOHANN JAKOB WENDLER, MAX SEIDENSTICKER, JENS RICKE, MACIEJ J. POWERSKI and MACIEJ PECH

Anticancer Research May 2019, 39 (5) 2501-2508; DOI: https://doi.org/10.21873/anticanres.13370
You have access
Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma
CONSTANZE HEINZE, JAZAN OMARI, MAX OTHMER, PETER HASS, MAX SEIDENSTICKER, ROBERT DAMM, JENS RICKE, MACIEJ PECH and MACIEJ J. POWERSKI

Anticancer Research September 2018, 38 (9) 5401-5407; DOI: https://doi.org/10.21873/anticanres.12870
You have access
Impact of Pleural Effusion on Outcomes of Patients Receiving Osimertinib for NSCLC Harboring EGFR T790M
KENTARO MASUHIRO, TAKAYUKI SHIROYAMA, HIDEKAZU SUZUKI, SO TAKATA, SHINGO NASU, HIROMUNE TAKADA, SATOMU MORITA, AYAKO TANAKA, NAOKO MORISHITA, NORIO OKAMOTO and TOMONORI HIRASHIMA

Anticancer Research June 2018, 38 (6) 3567-3571; DOI: https://doi.org/10.21873/anticanres.12629
You have access
Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma – A Comprehensive Review
TOMASZ BERUS, AGNIESZKA HALON, ANNA MARKIEWICZ, JOLANTA ORLOWSKA-HEITZMAN, BOZENA ROMANOWSKA-DIXON and PIOTR DONIZY

Anticancer Research December 2017, 37 (12) 6541-6549;
You have access
Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin Versus Temozolomide for the Treatment of Non-small Cell Lung Cancer with Brain Metastases
QIAOWEI HE, XIZHUANG BI, CHAO REN, YONG WANG, PENG ZOU, HONGTAO ZHANG, NAN CHI, CHUNMING XIU, YUNBO WANG and RONGJIE TAO

Anticancer Research August 2017, 37 (8) 4711-4716;

Main menu

User menu

Search

metastases

Pages